|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 47/18 | (2006.01) | ||
| A61K 47/06 | (2006.01) |
| (11) | Number of the document | 2335725 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10008980.4 |
| Date of filing the European patent application | 2004-03-29 | |
| (97) | Date of publication of the European application | 2011-06-22 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-12 |
| (46) | Date of publication of the claims translation | 2017-01-25 |
| (30) | Number | Date | Country code |
| 460659 P | 2003-04-04 | US |
| (72) |
Liu, Jun, US
Shire, Steven, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080-4990,
US
Novartis AG, Lichtstrasse 35, 4056 Basel, CH |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Didelės koncentracijos antikūno ir baltymo kompozicijos |
| High concentration antibody and protein formulations |
| Payment date | Validity (years) | Amount | |
| 2023-03-03 | 347.00 EUR |